ACQUIRED · 2021
Who Acquired Symplr?
Charlesbank Capital · $3.40B· 17.9× EBITDA
The acquisition
Symplr was acquired by Charlesbank Capital in 2021 for $3.40B. The deal was priced at 17.9× EBITDA.
Symplr at time of acquisition
EBITDA
$190.0M
Deal value
$3.40B
EV / EBITDA
17.9×
Similar healthcare it acquisitions
- Eucalyptus · acquired by Hims & Hers Health, Inc. in 2026 · $1.15B
- Gleamer SAS · acquired by RadNet, Inc. in 2026 · $251.6M
- HealthEZ · acquired by Blue Cross Blue Shield of New Jersey in 2026 · $360.0M
- Unbound Medicine · acquired by MPS Ltd in 2026 · $16.5M
- AccessOne · acquired by Phreesia, Inc. in 2025 · $160.0M
Run a valuation for a similar healthcare it business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the healthcare it calculator →More on healthcare it valuations
- Healthcare It valuation calculator· head-term variant
- Healthcare It median multiples· real-deal benchmarks
- How to value a healthcare it· long-form guide
Sourced from Press reporting. Full deal page.
Citation: ExitValue.ai. (2021). Symplr acquired by Charlesbank Capital. https://exitvalue.ai/acquired/symplr